Anticoagulant-induced Bleeding
34
4
5
14
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.9%
2 terminated out of 34 trials
87.5%
+1.0% vs benchmark
15%
5 trials in Phase 3/4
36%
5 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 14 completed trials
Clinical Trials (34)
LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology
Anticoagulation After GI Bleeding Pilot Study and Registry
Strategies for Anticoagulation During Venovenous ECMO
Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism
Peri-procedural Management of Direct Oral Anticoagulants for Central VENOus Catheters in CAncer Patients With Venous Thromboembolism or Atrial Fibrillation Pilot Study
Study of Antithrombotic Treatment After IntraCerebral Haemorrhage
The Effect of Prophylactic Anticoagulation on Major Bleeding Events in Hospitalized Chronic Kidney Disease and Lower Limb Fracture Patients.
Perioperative Management of Factor Xa Inhibitors
Comparing TR Band to Statseal in Conjunction With TR Band II
Optimization of Management in Patients With Cardiovascular Disease After Lower Limb Joint Replacement
Long-term Results of Percutaneous Left Atrial Closure at Brest University Hospital (CLAPOT)
Anticoagulation With Enhanced Gastrointestinal Safety
NOACs in Oral and Maxillofacial Surgery: Impact on Post-operative Complications
Rivaroxaban in Elderly Chinese Venous Thromboembolism Patients
Anticoagulant-associated Intracranial Hemorrhage
Baseline Concentration of Direct Oral Anticoagulant and Incidence of Adverse Event Measure And See (MAS)
Vitamin K Antagonist Versus Direct Oral Anticoagulant Treatments in Hemophilia
The Randomized OPTIMAL-ACT Trial
DOAC Versus VKA After Cardiac Surgery
The Third, Intensive Care Bundle With Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial